References
- Guide line: Manufacturing and Controls for INDs and NDAs. Pharm. Tech. Japan 1985; 1: 835, FDA Paper
- Sagawa J. Powder Technol. Jpn. 1983; 20: 738–743
- Morita M., Nakai Y., Fukuoka E., Nakajima S. Chem. Pharm. Bull. 1984; 32: 4076–4083
- Otsuka M., Kaneniwa N. Chem. Pharm. Bull. 1982; 31: 4489–4495
- Otsuka M., Kaneniwa N. Chem. Pharm. Bull. 1983; 32: 1071–1079
- Kaneniwa N., Otsuka M. Chem. Pharm. Bull. 1985; 33: 1660–1668
- Otsuka M., Kaneniwa N. J. Powder Technol. Jpn. 1985; 23: 63–67
- Otsuka M., Kaneniwa N. J. Pharm. Sci. 1986; 75: 506–511
- Otsuka M., Matsumoto T., Kaneniwa N. Chem. Pharm. Bull. 1986; 34: 1784–1790
- Otsuka M., Kaneniwa N. Chem. Pharm. Bull. 1983; 31: 230–236
- Borka L. Acta Pharm. Suecica 1974; 11: 295–303
- Fukuoka E., Makita M., Yamamura S. Chem. Pharm. Bull. 1986; 34: 4314–4321
- Fukuoka E., Makita M., Yamamura S. Abstract paper of 6th Symposium on Development and Evaluation of Pharmaceutical Preparations, Tokyo, Oct., 1985, 33p–36p
- Otsuka M., Kaneniwa N. Chem. Pharm. Bull. 1988; 36: 4026–4032